Cite

HARVARD Citation

    Lin, H. et al. (2021). Ropeginterferon alfa‐2b in patients with genotype 1 chronic hepatitis C: Pharmacokinetics, safety, and preliminary efficacy. JGH open. 5 (8), pp. 929-940. [Online]. 
  
Back to record